Logo image of OVXA.I

OVOCA BIO PLC (OVXA.I) Stock Fundamental Analysis

Europe - Euronext Dublin - DUB:OVXA - IE00B4XVDC01 - Common Stock

0.0105 EUR
0 (-8.7%)
Last: 4/30/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OVXA. OVXA was compared to 55 industry peers in the Pharmaceuticals industry. OVXA has a great financial health rating, but its profitability evaluates not so good. OVXA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • OVXA had negative earnings in the past year.
  • OVXA had a positive operating cash flow in the past year.
  • In the past 5 years OVXA always reported negative net income.
  • OVXA had negative operating cash flow in 4 of the past 5 years.
OVXA.I Yearly Net Income VS EBIT VS OCF VS FCFOVXA.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M

1.2 Ratios

  • With a Return On Assets value of -151.63%, OVXA is not doing good in the industry: 88.46% of the companies in the same industry are doing better.
  • OVXA has a worse Return On Equity (-210.00%) than 80.77% of its industry peers.
Industry RankSector Rank
ROA -151.63%
ROE -210%
ROIC N/A
ROA(3y)-77.44%
ROA(5y)-50.21%
ROE(3y)-100.76%
ROE(5y)-64.38%
ROIC(3y)N/A
ROIC(5y)N/A
OVXA.I Yearly ROA, ROE, ROICOVXA.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

  • OVXA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OVXA.I Yearly Profit, Operating, Gross MarginsOVXA.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, OVXA has more shares outstanding
  • OVXA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OVXA.I Yearly Shares OutstandingOVXA.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
OVXA.I Yearly Total Debt VS Total AssetsOVXA.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -5.71, we must say that OVXA is in the distress zone and has some risk of bankruptcy.
  • OVXA has a worse Altman-Z score (-5.71) than 75.00% of its industry peers.
  • OVXA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -5.71
ROIC/WACCN/A
WACCN/A
OVXA.I Yearly LT Debt VS Equity VS FCFOVXA.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 6.86 indicates that OVXA has no problem at all paying its short term obligations.
  • OVXA's Current ratio of 6.86 is amongst the best of the industry. OVXA outperforms 100.00% of its industry peers.
  • A Quick Ratio of 6.86 indicates that OVXA has no problem at all paying its short term obligations.
  • The Quick ratio of OVXA (6.86) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.86
Quick Ratio 6.86
OVXA.I Yearly Current Assets VS Current LiabilitesOVXA.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 9.01% over the past year.
EPS 1Y (TTM)9.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OVXA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OVXA.I Price Earnings VS Forward Price EarningsOVXA.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of OVXA indicates a rather cheap valuation: OVXA is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.3
EV/EBITDA N/A
OVXA.I Per share dataOVXA.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for OVXA!.
Industry RankSector Rank
Dividend Yield N/A

OVOCA BIO PLC / OVXA.I FAQ

Can you provide the ChartMill fundamental rating for OVOCA BIO PLC?

ChartMill assigns a fundamental rating of 2 / 10 to OVXA.I.


What is the valuation status of OVOCA BIO PLC (OVXA.I) stock?

ChartMill assigns a valuation rating of 2 / 10 to OVOCA BIO PLC (OVXA.I). This can be considered as Overvalued.


Can you provide the profitability details for OVOCA BIO PLC?

OVOCA BIO PLC (OVXA.I) has a profitability rating of 0 / 10.


Can you provide the financial health for OVXA stock?

The financial health rating of OVOCA BIO PLC (OVXA.I) is 7 / 10.